Regulation · September 2026
Regulation
Is PT-141 Legal in the UK? — Prescription Status and Research Supply
Bremelanotide is an approved medicine in the United States and is not one here. That single difference explains almost every confusing answer you will find about buying PT-141 peptide in Britain — and it decides what a UK supplier can legitimately sell it for.
The Short Answer
PT-141 can be supplied lawfully in the UK as a research chemical for laboratory use. It cannot be supplied, advertised or sold here as a medicine, because it does not hold a UK marketing authorisation.
Those are two different transactions with two different legal characters, and the distinction is not a technicality a supplier invented to cover itself. It determines what may be said about the compound, who it may be sold to, what the packaging may claim, and what happens if any of that is got wrong.
This covers regulatory status and how to verify a supplier’s claims. It is not medical or legal advice, it does not describe any use of PT-141 in people or animals, and it contains no dosing information of any kind. Pureline Biolabs supplies PT-141 strictly for in vitro laboratory research.
Why the Answer Sounds Contradictory Online
Search this question and you will find confident answers pointing in opposite directions. The reason is that people are answering about two different things without saying which.
Bremelanotide is the international non-proprietary name. PT-141 is the development code it carried through research, and the name the research-chemical market still uses. Same molecule, two names, and a great deal of confusion sits in the gap between them.
In the United States, bremelanotide was approved by the FDA in 2019 and is marketed there as a prescription product.1 That is a real approval, and it is frequently cited — usually without the words “in the United States” attached. A US approval confers nothing in Britain. Medicines licensing is national, and the MHRA makes its own determinations.
Is PT-141 Available on Prescription in the UK?
Not as a licensed product. If a medicine holds a UK marketing authorisation, it appears in the MHRA’s own products database with a Summary of Product Characteristics and a Patient Information Leaflet attached — that database is the public record, and it is searchable by active substance.2
That is the check anyone can run for themselves in about a minute, and it is worth running rather than taking any website’s word for it, including ours. If an active substance has no entry, there is no UK-licensed product containing it.
Prescribing an unlicensed medicine is a separate matter that sits between a clinician and their regulator, and it is not something a research-chemical supplier has any part in. What a supplier can say is narrow and it is the whole of our position: we sell laboratory research materials, not treatments.
What “Research Use Only” Actually Means
The phrase is used so often that it has started to read as boilerplate. It is not.
| Licensed medicine | Research-use material | |
|---|---|---|
| Legal basis | Marketing authorisation from the MHRA | Supplied as a chemical, not a medicinal product |
| Who it is for | Patients, via a prescriber or pharmacy | Laboratory research |
| Claims permitted | Those in the approved product information | None relating to treating, preventing or diagnosing anything |
| Quality framework | GMP manufacture, batch release, pharmacovigilance | Analytical characterisation; no clinical oversight |
| Advertising | Regulated, and restricted for prescription products | Must not promote any human use |
A supplier who sells research-use material while describing benefits, uses or doses for people has not found a clever loophole. They have made a claim that puts the product into the medicines regime, and it is the claim rather than the label that determines which set of rules applies. Our guide to UK peptide law and regulation covers how the MHRA approaches that question, and what responsible research-use supply looks like sets out the practical side.
Are There UK-Based Suppliers of PT-141?
Yes, and the distinction that matters is not where the website is registered but where the stock is and who tested it.
A UK-based supplier in any meaningful sense holds stock in Britain, dispatches from Britain, and is a registered UK company you can look up. Plenty of sites that read as British are order-forwarding operations: the vial ships from overseas when you buy it, which means customs risk, transit at uncontrolled temperature, and no realistic recourse if the order never arrives.
How to tell the difference in five minutes
- Look up the company. A UK limited company has a number you can check on the Companies House register. Pureline Biolabs Ltd is 17236739.
- Check where it ships from. If dispatch times are measured in weeks, the stock is not in the country.
- Ask for the batch certificate before ordering. Not a sample certificate — the one for the batch you would receive. If it only appears after payment, that is a decision they have made deliberately.
- Verify the certificate at the laboratory. A report from an independent laboratory can normally be checked on that laboratory’s own system. If it cannot be, you are trusting a PDF.
- Read what the site claims the product does. A supplier making human-use claims has already told you how carefully they read the rules.
The COA verification guide works through the fourth point properly, and decoding supplier quality claims covers the fifth.
Can PT-141 Be Legally Bought Online in the UK?
As a research chemical, from a supplier selling it as one, yes. What changes the answer is the purpose of the purchase and the claims wrapped around it.
Buying research material to use on yourself is not a transaction anyone can make lawful by relabelling it, and it is not a transaction we will knowingly take part in. Our PT-141 product page sells a laboratory research material, the batch certificate is published before the stock is listed, and there is no dosing guidance anywhere on this site because there is nothing legitimate to base it on.
Ordering from outside the UK adds a customs step that people consistently underestimate. Research chemicals can be held, inspected or seized, and a peptide sitting in a warehouse at ambient temperature for a fortnight has a quality problem regardless of what the certificate said when it left. Buying from UK-held stock avoids both.
What PT-141 Is, Briefly
PT-141 is a cyclic heptapeptide studied for activity at the melanocortin MC3R and MC4R receptors. It arose from research on melanocortin analogues and shares that lineage with Melanotan I, though the two are different molecules with different receptor profiles.
The lactam bridge that makes it cyclic leaves it more conformationally constrained and generally more resistant to enzymatic breakdown than an equivalent linear sequence. The full structural and research detail is on the PT-141 compound profile; this article is about status rather than science.
Pureline’s current batch is PLB-012, reported at 99.874% by HPLC at Janoshik Analytical, with the certificate published on the lab reports page before the stock went live.
What We Will Not Tell You
Some of the most-searched PT-141 questions are about dosing, effects and side effects in people. We do not answer them, and the reason is not caution for its own sake.
There is no legitimate basis from which a UK research-chemical supplier could derive a human dose. Doing so would mean presenting the product as a medicine, which is the precise thing that separates a lawful research supply from an unlawful one. A supplier who publishes a dosing chart has told you something useful about their compliance, just not the thing they intended.
If you are looking for information about bremelanotide as a treatment, that conversation belongs with a doctor, not with a peptide supplier.
Common Questions
Is PT-141 legal in the UK?
It can be supplied lawfully as a research chemical for laboratory use. It is not a licensed medicine in the UK, holds no UK marketing authorisation, and cannot lawfully be sold, advertised or supplied here as a treatment for anything.
Is PT-141 available on prescription in Britain?
Not as a licensed product. Licensed medicines appear in the MHRA products database with a Summary of Product Characteristics and Patient Information Leaflet, and that database is searchable by active substance so anyone can check it directly.
Is PT-141 the same as bremelanotide?
Yes. Bremelanotide is the international non-proprietary name and PT-141 is the development code from its research programme. The research-chemical market generally uses PT-141; regulatory and clinical literature uses bremelanotide.
Bremelanotide is approved in the US — does that apply here?
No. Medicines licensing is national. An FDA approval is a determination by a US regulator about a US product and confers no status in the United Kingdom, where the MHRA makes its own.
Are there UK-based suppliers of PT-141?
Yes, though many sites that appear British forward orders from overseas. A genuine UK supplier holds stock in the country, dispatches from it, and is a registered company you can look up on Companies House. Pureline Biolabs Ltd is company number 17236739 and holds UK stock under cold chain.
Can PT-141 be legally purchased online in the United Kingdom?
As a research chemical, from a supplier selling it as one, yes. Purchasing it for personal use is a different matter and not something relabelling makes lawful.
Where can I buy PT-141 peptide safely in the UK?
Safety here means verifiable rather than reassuring. Buy from UK-held stock so the vial has not spent weeks in transit, insist on seeing the batch certificate for your specific batch before you order, and verify that certificate at the issuing laboratory rather than trusting the PDF. Pureline publishes every batch report before listing the stock and prints the batch number on the vial.
What dose of PT-141 should I use?
We do not provide dosing information. There is no legitimate basis on which a UK research-chemical supplier could give one, and publishing a figure would mean presenting an unlicensed product as a medicine. Questions about bremelanotide as a treatment belong with a doctor.
What are the side effects of PT-141?
Any characterised safety profile for bremelanotide belongs to the approved US product and its prescribing information, under medical supervision. It does not transfer to a research chemical bought online, and we make no safety claims about material supplied for laboratory use.
References
- Bremelanotide: First Approval. Drugs. 2019. DOI: 10.1007/s40265-019-01187-w
- MHRA Products database — Summaries of Product Characteristics, Patient Information Leaflets and Public Assessment Reports for UK-licensed medicines, searchable by active substance. products.mhra.gov.uk
- Companies House register — public record of UK registered companies. Pureline Biolabs Ltd, company number 17236739.
Published by Pureline Biolabs Ltd, a UK-registered supplier of laboratory research materials, company number 17236739. Last reviewed September 2026. This article describes regulatory status and supplier verification. It is not medical or legal advice. Factual corrections are welcome through the contact page.
All products supplied by Pureline Biolabs Ltd are intended solely for in vitro laboratory research purposes. They are not medicines, not approved for human or veterinary use, and not for human consumption. Pureline Biolabs Ltd · Company No. 17236739 · purelinebiolabs.com

